Cancel
OK

You have successfully logged out.

Hello !
chevron_right My profile
chevron_right To My B. Braun overview
Logout

Antimicrobial Stewardship

Solutions that help protect patients, preserve antibiotics and secure our future.

Antimicrobial resistance is one of the greatest global health threats of our time. At B. Braun, we are committed to protecting patients and preserving the effectiveness of vital treatments through innovation, knowledge-sharing and sustainable design.

 

Antimicrobial Stewardship (AMS) is embedded in our ethos and our products, enabling healthcare professionals to deliver the right treatment, at the right time, for better outcomes and a protected future for all.

Health Care Professional Check

By clicking "Confirm” you declare that you are a health care professional. If you are a member of the public, we will redirect you to the pages dedicated to you.

Confirm Yes, I am a health care professional. Cancel No, I am not a health care professional.

Understanding the Challenges, Delivering the Solutions

  • Up to

    0%

    of an IV antibiotic dose never reaches the patient if the administration set line isn’t flushed1

  • 1 in 3 patients

    0%

    of UK sepsis patients are not receiving antibiotics within the recommended one‑hour window2

  • Equivalent of

    0 Tankers

    Nine oil tankers worth of antimicrobials are discarded each year in the UK1

 At B. Braun, best-practice antimicrobial stewardship is embedded in how we design, manufacture, deploy and support our infusion solutions.

Our three core principles focus on:

 

Bridging the Gap Between Prescription and Patient

Helping to ensure that antibiotics are delivered accurately, completely and consistently: supporting healthcare teams to strengthen stewardship at the point of care.

Sustainable Stewardship from Dose to Delivery

Helping to reduce waste, minimise environmental contamination and promote precision in antibiotic delivery.

Patient-Centred Stewardship

Helping to support faster recovery, earlier IV-to-oral switch, and continuity of care beyond the hospital, ensuring equitable access to effective treatment.

How B. Braun Helps

Effective Point-of-Care Stewardship

  • Up to 40% of an IV antibiotic dose never reaches the patient if lines aren’t flushed properly.1  Intrafix® SafeSet Flush enables total dose delivery to every patient.
  • With up to one in three UK Sepsis patients not receiving antibiotics within the recommended one‑hour window,2 ready‑to‑use, pre‑measured solutions help support faster, more accurate dosing and more consistent antimicrobial stewardship.3
  • Annual medication errors in England alone are estimated at 237 million,4 many linked to infusion. DoseTracPlus provides data-driven insights to find and fix infusion-related issues.

Sustainable Stewardship

  • Equivalent of 9 oil tankers worth of antimicrobials are discarded each year in the UK.1 Intrafix® SafeSet Flush ensures the total prescribed antibiotic dose is delivered to the patient helping to prevent inappropriate disposal, for example, down the sink or into waste streams creating aerosol vapours.
  • A sea of single-use plastics are attributed to traditional syringe preparation. Our ready-to-use solutions can reduce that waste by 81%.5
  • Traditional antibiotic preparation, using needle and syringe, can place healthcare professionals at risk of antibiotic exposure and needlestick injuries. Consistent use of CSTDs helps minimise these, supporting a safer working environment and reducing the potential for adverse health effects.8

Patient-Centred Stewardship

  • Accelerating best practice intravenous-to-oral-switch (IVOS). Our ready-to-use IV solutions help optimise antibiotic delivery, expediting patient stability and ability to safely go home more quickly.
  • Releasing up to 3,000 more beds daily with Outpatient Antibiotic Therapy (OPAT) and Outpatient Intravenous Therapy (OPIT) services.6 Our ready-to-use solutions extend good stewardship beyond hospital walls with more efficient, home-based IV infusion care.
  • Our most deprived communities in England experience 2–3x higher infection rates.7 Reduce variation and close care gaps with B. Braun’s standardised delivery solutions, reducing variation for all patients.

Supporting Smarter Stewardship:

Tools, Training & Insights

 

B. Braun Webinars & Symposia

Optimising IV Antibiotic Delivery

  • Dr. Emma Boldock, PhD MRCP FRCPath, Consultant Microbiologist and Infection Control Doctor, Sheffield Teaching Hospitals NHS Trust  
  • Claire Davies, Paediatric Nurse and Clinical Therapy Manager, B. Braun Medical Ltd 
  • Dr. Dagan Lonsdale, MBBS FFICM FRCP SFHEA PhD, Reader in Clinical Pharmacology and Intensive Care Medicine, Consultant Intensivist, St George’s University Hospitals NHS Foundation Trust
  • Ruth Dando, Head of Theatres, Critical Care and Anaesthetics, Barking, Havering and Redbridge University Hospitals NHS Trust

Optimising IV Antibiotic Delivery

  • Accelerating best practice intravenous-to-oral-switch (IVOS). Our ready-to-use IV solutions help optimise antibiotic delivery, expediting patient stability and ability to safely go home more quickly.

    Releasing up to 3,000 more beds daily with Outpatient Antibiotic Therapy (OPAT) and Outpatient Intravenous Therapy (OPIT) services.(6) Our ready-to-use solutions extend good stewardship beyond hospital walls with more efficient, home-based IV infusion care.

    Our most deprived communities in England experience 2–3x higher infection rates.(7) Reduce variation and close care gaps with B. Braun’s standardised delivery solutions, reducing variation for all patients.

Understanding the SNAP Trial and the Management of Staphylococcus Aureus Bacteraemia

  • Dr. Emma Boldock, PhD MRCP FRCPath, Consultant Microbiologist and Infection Control Doctor, Sheffield Teaching Hospitals NHS Trust
  • Dr. Anna Goodman, Infectious Diseases Consultant, Guy’s and St Thomas’ NHS Foundation Trust, London 
  • Dr. Abi Jenkins, Advanced Pharmacist Infection Prevention and Control University Hospitals Birmingham NHS Foundation Trust 

Advancements in IV Administration: The Issue of Underdosing

Mark Santillo – Former Chair of the NHS Pharmaceutical Quality Assurance Committee

Implementing IV Line Flushing Guidance in Critical Care

Kate Holland – Royal Bournemouth Hospital

National Guidance

Ensure every dose counts 


Get in touch to explore solutions that help protect patients, preserve the planet and secure our future 

Contact

Related Documents

  • Ready-to-Use Antibiotic (RTUA) Bag Poster

    An Innovative IV Antibiotic Preparation Device to Release Time to Care and Aseptic Capacity

    pdf, 824.2 KB

    download Download

References

1. Santillo, M. (2022) IV Forum; Advancements in IV Administration, Available at: https://www.youtube.com/watch?v=0WAupmxRDTY

2. NIHR Dissemination Centre. (2017) Giving immediate antibiotics reduces deaths from sepsis. Available at: https://evidence.nihr.ac.uk/alert/giving-immediate-antibiotics-reduces-deaths-from-sepsis/

3. Al Rawi, S. (2024) Ready to administer, ready to save: Enhancing safety and value with RTA injectables. NHS England, Infusions and Special Medicines Programme. Available at: https://pasg.nhs.uk/downloads.php?did=772&filename=Ready%20to%20administer%2C%20ready%20to%20save_Suzanne%20Al-Rawi.pdf

4. Hodkinson, A., Tyler, N., Ashcroft, D.M. et al. (2020) Preventable medication harm across health care settings: a systematic review and meta-analysis. BMC Med 18, 313. Available at: https://doi.org/10.1186/s12916-020-01774-9

5. B. Braun. (2024) An innovative IV antibiotic preparation device to release time to care and aseptic capacity.

6. Transforming NHS Pharmacy Aseptic Services in England. (2020) A national report for the Department of Health and Social Care by Lord Carter of Coles. Available at: https://assets.publishing.service.gov.uk/media/5f9afdbdd3bf7f1e405d9a23/aseptic-pharmacy.pdf

7. Public Health England (2018) Health Profile for England. London: Public Health England. Available at: https://www.gov.uk/government/publications/health-profile-for-england-2018

8. Sessink, P.J.M., Tans, B., Spriet, I. and Devolder, D. (2024) ‘Longitudinal evaluation of environmental contamination with hazardous drugs by surface wipe sampling’, Journal of Oncology Pharmacy Practice, 30(7), pp. 1181–1185. https://doi.org/10.1177/10781552231205481 [pmc.ncbi.nlm.nih.gov]